Last July, U.K. national Mark Reilly, a career man at drug maker GlaxoSmithKline PLC who had risen up the ranks to head its China operations, returned to his home country on a planned vacation for a few weeks.

Weeks earlier, several of Glaxo's offices in China had been raided by law-enforcement officials who had seized documents and detained some employees. Mr. Reilly wasn't detained, although he knew about the visits, according to a person familiar with the matter. Officials publicly accused Glaxo of corruption the same...